Teriflunomide (Therapeutic Drug Monitoring), Serum/Plasma Test (4366SP)

Teriflunomide (Therapeutic Drug Monitoring), Serum/Plasma Test (4366SP)

Analysis Code 4366SP 
Test Name Teriflunomide (Therapeutic Drug Monitoring), Serum/Plasma 
Test Includes Teriflunomide 
Compound Synonym(s) Aubagio┬« 
Purpose This test is designed for the therapeutic drug monitoring of teriflunomide levels to ensure adequate dosage. The minimum reporting limit of this assay is 500 ng/mL. THIS TEST IS NOT MEANT TO MONITOR THE ELIMINATION OF TERIFLUNOMIDE IN WOMEN OF CHILDBEARING POTENTIAL WHO DISCONTINUE TERIFLUNOMIDE. This test is New York State approved. 
Category Immunomodulator 
Method(s) High Performance Liquid Chromatography/
TandemMass Spectrometry (LC-MS/MS) 
Specimen Requirements 1 mL Serum or Plasma 
Transport Temperature Refrigerated 
Specimen Container Plastic container (preservative-free) 
Special Handling Serum: Collect sample in Red top tube
Plasma: Collect sample in Lavender top tube (EDTA) or Pink top tube.
Promptly centrifuge and separate Serum or Plasma into a plastic screw capped vial using approved guidelines. 
Light Protection Required Not Required 
Stability Room Temperature: 30 day(s)
Refrigerated: 30 day(s)
Frozen (-20 ┬░C): 10 month(s) 
*Rejection Criteria Polymer gel separation tube (SST or PST). 
Day(s) Test Set-up / TAT [LC-MS/MS] Monday-Sunday / 7 days 
Suggested CPT Code 80375 
**Minimum Volume 0.2025 mL 
Test Summary Sheet Generate  

You are viewing Teriflunomide (Therapeutic Drug Monitoring), Serum/Plasma Test (4366SP)
*Rejection criteria pertain to clinical specimen submissions only.
**Stated minimum volume allows for a single analysis. Repeat analysis will not be performed.


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9

Enter your e-mail address if you would like NMS Labs to add this test to the selection of tests that can be purchased by using a credit card versus traditional ordering methods.